Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | ZyVersa Therapeutics, |
Description | ZyVersa Therapeutics, Inc. --> Navigate ZyVersa Therapeutics, Inc. Home About About Our Vision/Mission Management Team CEOCFO Magazine Interview With C |
Keywords | N/A |
WebSite | variantpharma.com |
Host IP | 52.23.24.89 |
Location | United States |
Site | Rank |
US$1,124
Last updated: 2023-05-13 08:24:13
variantpharma.com has Semrush global rank of 0. variantpharma.com has an estimated worth of US$ 1,124, based on its estimated Ads revenue. variantpharma.com receives approximately 129 unique visitors each day. Its web server is located in United States, with IP address 52.23.24.89. According to SiteAdvisor, variantpharma.com is safe to visit. |
Purchase/Sale Value | US$1,124 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$31 |
Yearly Ads Revenue | US$373 |
Daily Unique Visitors | 8 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
variantpharma.com. | A | 300 | IP: 52.23.24.89 |
variantpharma.com. | A | 300 | IP: 3.221.176.71 |
variantpharma.com. | A | 300 | IP: 54.92.242.51 |
variantpharma.com. | A | 300 | IP: 54.204.124.209 |
variantpharma.com. | NS | 86400 | NS Record: ns-1292.awsdns-33.org. |
variantpharma.com. | NS | 86400 | NS Record: ns-1836.awsdns-37.co.uk. |
variantpharma.com. | NS | 86400 | NS Record: ns-505.awsdns-63.com. |
variantpharma.com. | NS | 86400 | NS Record: ns-624.awsdns-14.net. |
variantpharma.com. | MX | 300 | MX Record: 0 variantpharma-com.mail.protection.outlook.com. |
variantpharma.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
ZyVersa Therapeutics, Inc. --> Navigate ZyVersa Therapeutics, Inc. Home About About Our Vision/Mission Management Team CEOCFO Magazine Interview With CEO Board of Directors Scientific Advisory Board: Inflammatory Diseases Scientific Advisory Board: Renal Disease Inflammasomes Inflammasomes IC 100: ASC Inhibitor IC 100: MOA Presentation IC 100: MOA Video IC 100 Infographic, Mechanism of Action ASC Biomarker Inflammasome Publications White Paper: Inflammasomes, a Promising Therapeutic and Diagnostic Target Renal Lipids Renal Lipids Cholesterol Efflux Mediator™ VAR 200 White Paper: Renal Lipids in the Pathogenesis of Kidney Disease Video: Renal Lipids and Kidney Disease Publications Pipeline Pipeline Collaboration About FSGS About Alport Syndrome About Diabetic Kidney Disease About Multiple Sclerosis Careers Investors & Media Contact Restoring Health, Transforming Lives Through Innovation ZyVersa is committed to improving health outcomes and quality of life for patients with |
HTTP/1.1 301 Moved Permanently Content-Type: text/html; charset=UTF-8 Date: Tue, 21 Dec 2021 01:33:00 GMT Location: http://www.zyversa.com/ Server: Apache Connection: keep-alive HTTP/1.1 302 Moved Temporarily Content-Type: text/html; charset=UTF-8 Date: Tue, 21 Dec 2021 01:33:00 GMT Location: https://www.zyversa.com/ Server: Apache Connection: keep-alive HTTP/1.1 200 OK Date: Tue, 21 Dec 2021 01:33:00 GMT Server: Apache Content-Type: text/html; charset=UTF-8 |
Domain Name: VARIANTPHARMA.COM Registry Domain ID: 1844794733_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-02-14T01:15:54Z Creation Date: 2014-01-30T15:29:48Z Registry Expiry Date: 2023-01-30T15:29:48Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1292.AWSDNS-33.ORG Name Server: NS-1836.AWSDNS-37.CO.UK Name Server: NS-505.AWSDNS-63.COM Name Server: NS-624.AWSDNS-14.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T08:14:58Z <<< |